Dynavax Technologies Corporation (DVAX)
USD 12.25
(-3.2%)
USD 12.25
(-3.2%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 252.41 Million USD | -0.77% |
| 2022 | 254.37 Million USD | -0.17% |
| 2021 | 254.8 Million USD | 18.74% |
| 2020 | 214.6 Million USD | -0.85% |
| 2019 | 216.44 Million USD | 114.58% |
| 2018 | 100.87 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 9.55 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 11.78 Million USD | 26.12% |
| 2009 | 9.34 Million USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 222.98 Million USD | 0.13% |
| 2024 Q2 | 223.27 Million USD | 0.13% |
| 2023 Q3 | 253.09 Million USD | -0.23% |
| 2023 Q4 | 252.41 Million USD | -0.27% |
| 2023 Q2 | 253.67 Million USD | -0.12% |
| 2023 FY | 252.41 Million USD | -0.77% |
| 2023 Q1 | 253.98 Million USD | -0.15% |
| 2022 Q1 | 255.01 Million USD | 0.08% |
| 2022 Q3 | 254.43 Million USD | -0.11% |
| 2022 Q4 | 254.37 Million USD | -0.02% |
| 2022 Q2 | 254.7 Million USD | -0.12% |
| 2022 FY | 254.37 Million USD | -0.17% |
| 2021 Q2 | 252.85 Million USD | 18.33% |
| 2021 FY | 254.8 Million USD | 18.74% |
| 2021 Q1 | 213.68 Million USD | -0.43% |
| 2021 Q4 | 254.8 Million USD | -0.14% |
| 2021 Q3 | 255.15 Million USD | 0.91% |
| 2020 Q1 | 216.55 Million USD | 0.05% |
| 2020 Q4 | 214.6 Million USD | -0.3% |
| 2020 Q2 | 215.88 Million USD | -0.31% |
| 2020 Q3 | 215.25 Million USD | -0.29% |
| 2020 FY | 214.6 Million USD | -0.85% |
| 2019 Q3 | 214.57 Million USD | 1.56% |
| 2019 FY | 216.44 Million USD | 114.58% |
| 2019 Q1 | 210.74 Million USD | 108.93% |
| 2019 Q2 | 211.27 Million USD | 0.25% |
| 2019 Q4 | 216.44 Million USD | 0.87% |
| 2018 Q4 | 100.87 Million USD | 0.55% |
| 2018 Q2 | 99.77 Million USD | 0.54% |
| 2018 Q1 | 99.23 Million USD | 0.0% |
| 2018 FY | 100.87 Million USD | 0.0% |
| 2018 Q3 | 100.31 Million USD | 0.55% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q1 | 8.91 Million USD | -6.76% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | -100.0% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q2 | 7.96 Million USD | -10.68% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | 9.55 Million USD | 0.0% |
| 2014 FY | 9.55 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 Q3 | 12.34 Million USD | -3.08% |
| 2011 FY | - USD | -100.0% |
| 2011 Q1 | 11.4 Million USD | -3.18% |
| 2011 Q2 | 12.73 Million USD | 11.63% |
| 2011 Q4 | - USD | -100.0% |
| 2010 FY | 11.78 Million USD | 26.12% |
| 2010 Q2 | 13.3 Million USD | 3.51% |
| 2010 Q1 | 12.85 Million USD | 37.55% |
| 2010 Q3 | 11.48 Million USD | -13.66% |
| 2010 Q4 | 11.78 Million USD | 2.59% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | 9.34 Million USD | 0.0% |
| 2009 Q4 | 9.34 Million USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cosmos Health Inc. | 3.03 Million USD | -8215.968% |
| Safety Shot Inc | 304.9 Thousand USD | -82685.243% |
| Bright Green Corporation | 201.78 Thousand USD | -124993.789% |
| Embecta Corp. | 1.62 Billion USD | 84.47% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 18.488% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | -177.151% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 48.482% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 49.672% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -1794.177% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 50.872% |
| PainReform Ltd. | 30 Thousand USD | -841293.333% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -46727.757% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -46727.757% |
| SCYNEXIS, Inc. | 12.15 Million USD | -1975.977% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -215404.273% |
| Journey Medical Corporation | 14.62 Million USD | -1626.289% |
| Alpha Teknova, Inc. | 13.25 Million USD | -1804.898% |
| Procaps Group, S.A. | 28.41 Million USD | -788.483% |
| Theratechnologies Inc. | 51.26 Million USD | -392.417% |
| Harrow Health, Inc. | 183.17 Million USD | -37.804% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -290035.632% |
| Biofrontera Inc. | 804 Thousand USD | -31295.274% |
| DURECT Corporation | 2.7 Million USD | -9241.895% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -660.387% |
| Cronos Group Inc. | 1.55 Million USD | -16091.02% |
| OptiNose, Inc. | 611 Thousand USD | -41212.275% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 49.345% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -638.28% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -55376.484% |
| Organogenesis Holdings Inc. | 60.74 Million USD | -315.537% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -1874.461% |
| Radius Health, Inc. | 339.66 Million USD | 25.686% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -2360.694% |
| Phibro Animal Health Corporation | 458.28 Million USD | 44.922% |
| Procaps Group S.A. | 28.41 Million USD | -788.483% |
| Alvotech | 1.02 Billion USD | 75.44% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -3764.329% |
| Viatris Inc. | 16.18 Billion USD | 98.441% |
| Rockwell Medical, Inc. | 8.29 Million USD | -2943.748% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -2220.658% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -75026.417% |
| Tilray Brands, Inc. | 287.93 Million USD | 12.335% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | -109.458% |
| Shineco, Inc. | 10.01 Million USD | -2419.813% |
| PetIQ, Inc. | 437.82 Million USD | 42.347% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -120099.048% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 2.277% |
| Alimera Sciences, Inc. | 64.48 Million USD | -291.412% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | -555.393% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -186753.112% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -3580.977% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -34958.056% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -1122556.111% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -670.507% |
| Hempacco Co., Inc. | 5.93 Million USD | -4155.909% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 75.44% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | -349.015% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 59.031% |
| Currenc Group, Inc. | 2.5 Million USD | -9968.633% |
| Kamada Ltd. | 7.43 Million USD | -3293.627% |
| Indivior PLC | 235.66 Million USD | -7.108% |
| Evoke Pharma, Inc. | 5 Million USD | -4948.36% |
| Flora Growth Corp. | 942 Thousand USD | -26695.966% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -1122556.111% |
| Evolus, Inc. | 120.35 Million USD | -109.721% |
| HUTCHMED (China) Limited | 48.18 Million USD | -423.808% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 57.159% |
| Akanda Corp. | 2.49 Million USD | -10008.223% |